PTPRC and acute lymphoblastic leukemia: Taken together, in NOTCH1Mutated T-ALL samples, a CD45+CD34+CD2+CD7+ population is enriched for LIC that demonstrate serial leukemic transplantation capacity, and these cells are selectively targeted and depleted by hN1 antibody therapy.